These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

218 related articles for article (PubMed ID: 19318546)

  • 1. Clock-cancer connection in non-Hodgkin's lymphoma: a genetic association study and pathway analysis of the circadian gene cryptochrome 2.
    Hoffman AE; Zheng T; Stevens RG; Ba Y; Zhang Y; Leaderer D; Yi C; Holford TR; Zhu Y
    Cancer Res; 2009 Apr; 69(8):3605-13. PubMed ID: 19318546
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The core circadian gene Cryptochrome 2 influences breast cancer risk, possibly by mediating hormone signaling.
    Hoffman AE; Zheng T; Yi CH; Stevens RG; Ba Y; Zhang Y; Leaderer D; Holford T; Hansen J; Zhu Y
    Cancer Prev Res (Phila); 2010 Apr; 3(4):539-48. PubMed ID: 20233903
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Phenotypic effects of the circadian gene Cryptochrome 2 on cancer-related pathways.
    Hoffman AE; Zheng T; Ba Y; Stevens RG; Yi CH; Leaderer D; Zhu Y
    BMC Cancer; 2010 Mar; 10():110. PubMed ID: 20334671
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Genetic variation in tumor necrosis factor and the nuclear factor-kappaB canonical pathway and risk of non-Hodgkin's lymphoma.
    Cerhan JR; Liu-Mares W; Fredericksen ZS; Novak AJ; Cunningham JM; Kay NE; Dogan A; Liebow M; Wang AH; Call TG; Habermann TM; Ansell SM; Slager SL
    Cancer Epidemiol Biomarkers Prev; 2008 Nov; 17(11):3161-9. PubMed ID: 18990758
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The circadian gene CRY2 is associated with breast cancer aggressiveness possibly via epigenomic modifications.
    Mao Y; Fu A; Hoffman AE; Jacobs DI; Jin M; Chen K; Zhu Y
    Tumour Biol; 2015 May; 36(5):3533-9. PubMed ID: 25740058
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ala394Thr polymorphism in the clock gene NPAS2: a circadian modifier for the risk of non-Hodgkin's lymphoma.
    Zhu Y; Leaderer D; Guss C; Brown HN; Zhang Y; Boyle P; Stevens RG; Hoffman A; Qin Q; Han X; Zheng T
    Int J Cancer; 2007 Jan; 120(2):432-5. PubMed ID: 17096334
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Polymorphisms in oxidative stress genes and risk for non-Hodgkin lymphoma.
    Wang SS; Davis S; Cerhan JR; Hartge P; Severson RK; Cozen W; Lan Q; Welch R; Chanock SJ; Rothman N
    Carcinogenesis; 2006 Sep; 27(9):1828-34. PubMed ID: 16543247
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Genetic variation in DNA repair pathways and risk of non-Hodgkin's lymphoma.
    Rendleman J; Antipin Y; Reva B; Adaniel C; Przybylo JA; Dutra-Clarke A; Hansen N; Heguy A; Huberman K; Borsu L; Paltiel O; Ben-Yehuda D; Brown JR; Freedman AS; Sander C; Zelenetz A; Klein RJ; Shao Y; Lacher M; Vijai J; Offit K; Kirchhoff T
    PLoS One; 2014; 9(7):e101685. PubMed ID: 25010664
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Polymorphisms in DNA repair genes and risk of non-Hodgkin's lymphoma in New South Wales, Australia.
    Shen M; Purdue MP; Kricker A; Lan Q; Grulich AE; Vajdic CM; Turner J; Whitby D; Chanock S; Rothman N; Armstrong BK
    Haematologica; 2007 Sep; 92(9):1180-5. PubMed ID: 17666372
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The role of polymorphisms in circadian pathway genes in breast tumorigenesis.
    Dai H; Zhang L; Cao M; Song F; Zheng H; Zhu X; Wei Q; Zhang W; Chen K
    Breast Cancer Res Treat; 2011 Jun; 127(2):531-40. PubMed ID: 20978934
    [TBL] [Abstract][Full Text] [Related]  

  • 11. High-resolution loss of heterozygosity screening implicates PTPRJ as a potential tumor suppressor gene that affects susceptibility to Non-Hodgkin's lymphoma.
    Aya-Bonilla C; Green MR; Camilleri E; Benton M; Keane C; Marlton P; Lea R; Gandhi MK; Griffiths LR
    Genes Chromosomes Cancer; 2013 May; 52(5):467-79. PubMed ID: 23341091
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Insect cryptochromes: gene duplication and loss define diverse ways to construct insect circadian clocks.
    Yuan Q; Metterville D; Briscoe AD; Reppert SM
    Mol Biol Evol; 2007 Apr; 24(4):948-55. PubMed ID: 17244599
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Germline variation in apoptosis pathway genes and risk of non-Hodgkin's lymphoma.
    Kelly JL; Novak AJ; Fredericksen ZS; Liebow M; Ansell SM; Dogan A; Wang AH; Witzig TE; Call TG; Kay NE; Habermann TM; Slager SL; Cerhan JR
    Cancer Epidemiol Biomarkers Prev; 2010 Nov; 19(11):2847-58. PubMed ID: 20855536
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CLOCK in breast tumorigenesis: genetic, epigenetic, and transcriptional profiling analyses.
    Hoffman AE; Yi CH; Zheng T; Stevens RG; Leaderer D; Zhang Y; Holford TR; Hansen J; Paulson J; Zhu Y
    Cancer Res; 2010 Feb; 70(4):1459-68. PubMed ID: 20124474
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clock-cancer connection in non-Hodgkin's lymphoma.
    Zhu Y; Zheng T
    Med Hypotheses; 2008; 70(4):788-92. PubMed ID: 17935900
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Circadian Gene Polymorphisms Associated with Breast Cancer Susceptibility.
    Lesicka M; Jabłońska E; Wieczorek E; Pepłońska B; Gromadzińska J; Seroczyńska B; Kalinowski L; Skokowski J; Reszka E
    Int J Mol Sci; 2019 Nov; 20(22):. PubMed ID: 31739444
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Association of XRCC1 genetic polymorphism with susceptibility to non-Hodgkin's lymphoma].
    Li SX; Zhu HL; Guo B; Yang Y; Wang HY; Sun JF; Cao YB
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2014 Aug; 22(4):982-7. PubMed ID: 25130814
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Genetic variation in Th1/Th2 pathway genes and risk of non-Hodgkin lymphoma: a pooled analysis of three population-based case-control studies.
    Lan Q; Wang SS; Menashe I; Armstrong B; Zhang Y; Hartge P; Purdue MP; Holford TR; Morton LM; Kricker A; Cerhan JR; Grulich A; Cozen W; Zahm SH; Yeager M; Vajdic CM; Schenk M; Leaderer B; Yuenger J; Severson RK; Chatterjee N; Chanock SJ; Zheng T; Rothman N
    Br J Haematol; 2011 May; 153(3):341-50. PubMed ID: 21418175
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Suppression of circadian clock protein cryptochrome 2 promotes osteoarthritis.
    Bekki H; Duffy T; Okubo N; Olmer M; Alvarez-Garcia O; Lamia K; Kay S; Lotz M
    Osteoarthritis Cartilage; 2020 Jul; 28(7):966-976. PubMed ID: 32339698
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sleep deprivation effects on circadian clock gene expression in the cerebral cortex parallel electroencephalographic differences among mouse strains.
    Wisor JP; Pasumarthi RK; Gerashchenko D; Thompson CL; Pathak S; Sancar A; Franken P; Lein ES; Kilduff TS
    J Neurosci; 2008 Jul; 28(28):7193-201. PubMed ID: 18614689
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.